| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2000 | US6093728 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds |
| 07/25/2000 | US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion |
| 07/25/2000 | US6093724 Muscarinic agonists and antagonists |
| 07/25/2000 | US6093723 An immunomodulator for treating and preventing immune disorders, including autoimmune disease, inflammatory disease, organ transplant rejection and other disorders associated with il-2 mediated immune response |
| 07/25/2000 | US6093722 Administering an anticancer drug n-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a testosterone 5-alpha reductase enzyme inhibitor |
| 07/25/2000 | US6093721 Amidino-camptothecin derivatives |
| 07/25/2000 | US6093720 An antioxidant, antiischemic as well as antiamnesic effects for inhibiting lipid peroxidation, treating various degenerative neurological diseases alzheimer's disease |
| 07/25/2000 | US6093719 Method and pharmaceutical composition for regulating lipid concentration |
| 07/25/2000 | US6093718 An oxido-squalene cyclase inhibitor, anticholesterol agent for inhibiting cholesterol biosynthesis and lowering cholesterol levels in blood plasma; treating hypercholesterolemia and atherosclerosis |
| 07/25/2000 | US6093717 Imidazopyridine thrombin inhibitors |
| 07/25/2000 | US6093716 Substituted 2-pyrimidineamines and processes for their preparation |
| 07/25/2000 | US6093715 Process for producing riboflavin-containing granules |
| 07/25/2000 | US6093713 A tyrosine kinase inhibitor for enhancing the function of a cholinergic neuron |
| 07/25/2000 | US6093711 Enteric-coated chromium picolinate compositions and uses thereof |
| 07/25/2000 | US6093710 Benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/25/2000 | US6093709 Administering a therapeutic beta isozyme of protein kinase c inhibitor for inducing smooth muscle relaxation and vasodilation |
| 07/25/2000 | US6093708 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 07/25/2000 | US6093707 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/25/2000 | US6093706 Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders |
| 07/25/2000 | US6093705 Methods and compositions for sedating, anaesthetizing and euthanizing aquatic organisms |
| 07/25/2000 | US6093704 Use of dopamine receptor antagonists in palliative tumor therapy |
| 07/25/2000 | US6093703 Pharmaceutical compositions, containing S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid and 5-formyltetrahydrofolic acid |
| 07/25/2000 | US6093702 Synergistic mixture of 2',3'-dideoxyinosine and hydroxycarbamide; administering to host in given dosage to inhibit human immunodeficiency virus(hiv) in cells |
| 07/25/2000 | US6093698 Polysubstituted benzimidazoles as antiviral agents |
| 07/25/2000 | US6093697 Derivatives of small amino disaccharides of given formula; for treatment of disorders of glucose metabolism |
| 07/25/2000 | US6093564 Methods and compositions for the selective modification of nucleic acids |
| 07/25/2000 | US6093532 Method for storing a biological organ transplant graft using a benzisoselen-azoline or -azine compound |
| 07/25/2000 | US6093420 Sustained release matrix for high-dose insoluble drugs |
| 07/25/2000 | US6093411 Compositions for regulating skin appearance |
| 07/25/2000 | US6093398 Treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction |
| 07/25/2000 | US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts |
| 07/25/2000 | US6093391 Peptide compositions containing polyoxyethylene-polyoxypropylene block copolymers that are useful in treatment of diseases and disorders with reduced side effects, ease in administering to desired target site, |
| 07/25/2000 | US6093388 Mannose-6-phosphate composition and its use in treating fibrotic disorders |
| 07/25/2000 | US6093385 For protecting the human skin or human hair from the sun's rays |
| 07/25/2000 | US6093382 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 07/25/2000 | US6093348 Aqueous suspension of carotenoid is heated to melt the carotenoid, the suspension is then homogenized under pressure to form an emulsion, and the resulting emulsion is dried to obtain the carotenoid powder |
| 07/25/2000 | CA2205285C Benzoic acid derivative and pharmaceutical composition |
| 07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 07/25/2000 | CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives |
| 07/25/2000 | CA2167688C Methods and compositions for inhibiting uridine secretion |
| 07/25/2000 | CA2141029C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2031890C N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives |
| 07/25/2000 | CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 07/20/2000 | WO2000043005A1 Treatment of neoplasms with the yujungamycins |
| 07/20/2000 | WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | WO2000042213A1 A novel method for designing protein kinase inhibitors |
| 07/20/2000 | WO2000042202A1 A method for introducing substances into cells, and use of said method |
| 07/20/2000 | WO2000042201A2 Human peptidases |
| 07/20/2000 | WO2000042181A1 Minor histocompatibility antigens and their use in diagnosis and treatment of tumors |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042173A1 Catalytic molecules |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 07/20/2000 | WO2000042060A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | WO2000042058A1 Steroid derived antibiotics |
| 07/20/2000 | WO2000042056A1 Method for preparing an aza-macrolide with 4'' (r) nh¿2? |
| 07/20/2000 | WO2000042055A2 Macrolides with anti-inflammatory activity |
| 07/20/2000 | WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042050A1 Sulfated phosphatidylinositols, their preparation and use |
| 07/20/2000 | WO2000042047A1 4-phenoxymethyl-substituted milbemycins |
| 07/20/2000 | WO2000042045A2 Functionalized heterocycles as chemokine receptor modulators |
| 07/20/2000 | WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | WO2000042042A2 High affinity inhibitors for target validation and uses thereof |
| 07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042034A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000042030A1 Hypolipidemic and antioxidant morpholine derivatives |
| 07/20/2000 | WO2000042029A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | WO2000042027A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
| 07/20/2000 | WO2000042025A1 Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives |
| 07/20/2000 | WO2000042024A1 Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042022A1 Benzoheterocycles and their use as mek inhibitors |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042017A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042011A1 Amide compounds |
| 07/20/2000 | WO2000042010A1 Contrast media for angiography |
| 07/20/2000 | WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea |
| 07/20/2000 | WO2000042004A1 Benzenic sulphonamide derivatives and their uses |
| 07/20/2000 | WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | WO2000042001A1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 07/20/2000 | WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | WO2000041992A1 Reductive alkylation of secondary amines with hydrosilane |
| 07/20/2000 | WO2000041985A1 Process and products of purification of anhydrosugar alcohols |
| 07/20/2000 | WO2000041740A2 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | WO2000041730A1 A composition and method for the enhancement of the efficacy of drugs |
| 07/20/2000 | WO2000041729A1 Remedies for corneal disorders |
| 07/20/2000 | WO2000041728A1 Compositions for treating frequent urination and urinary incontinence |